Smart therapies against global pandemics: A potential of short peptides

Smart therapies against global pandemics: A potential of short peptides

Bibliographic Details
Main Authors:	Vasso Apostolopoulos, Joanna Bojarska, Jack Feehan, John Matsoukas, Wojciech Wolf
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-08-01
Series:	Frontiers in Pharmacology
Subjects:	pandemics short peptides viral and bacterial infections bioterrorism smart therapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.914467/full

Similar Items

The Use of Electrochemical Voltammetric Techniques and High-Pressure Liquid Chromatography to Evaluate Conjugation Efficiency of Multiple Sclerosis Peptide-Carrier Conjugates
by: Efstathios Deskoulidis, et al.
Published: (2020-08-01)

Design of Linear and Cyclic Mutant Analogues of Dirucotide Peptide (MBP<sub>82–98</sub>) against Multiple Sclerosis: Conformational and Binding Studies to MHC Class II
by: George Deraos, et al.
Published: (2018-12-01)

The Long Road of Immunotherapeutics against Multiple Sclerosis
by: Vasso Apostolopoulos, et al.
Published: (2020-05-01)

Development of Methamphetamine Conjugated Vaccine through Hapten Design: In Vitro and In Vivo Characterization
by: Md Kamal Hossain, et al.
Published: (2023-02-01)

Peptide-Drug Conjugates: A New Hope for Cancer Management
by: Vivek P. Chavda, et al.
Published: (2022-10-01)

From Angiotensin II to Cyclic Peptides and Angiotensin Receptor Blockers (ARBs): Perspectives of ARBs in COVID-19 Therapy
by: John Matsoukas, et al.
Published: (2021-01-01)

Novel Approaches in the Immunotherapy of Multiple Sclerosis: Cyclization of Myelin Epitope Peptides and Conjugation with Mannan
by: John M. Matsoukas, et al.
Published: (2021-11-01)

Myelin Peptide–Mannan Conjugate Multiple Sclerosis Vaccines: Conjugation Efficacy and Stability of Vaccine Ingredient
by: John Matsoukas, et al.
Published: (2021-12-01)

Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review
by: Vivek P. Chavda, et al.
Published: (2022-07-01)

A Global Review on Short Peptides: Frontiers and Perspectives
by: Vasso Apostolopoulos, et al.
Published: (2021-01-01)

New Advances in Short Peptides: Looking Forward
by: Vasso Apostolopoulos, et al.
Published: (2022-06-01)

Mannosylated linear and cyclic single amino acid mutant peptides using a small 10 amino acid linker constitute promising candidates against Multiple Sclerosis
by: Stephanie eDay, et al.
Published: (2015-04-01)

The Human Myelin Proteome and Sub-Metalloproteome Interaction Map: Relevance to Myelin-Related Neurological Diseases
by: Christos T. Chasapis, et al.
Published: (2022-03-01)

Evaluation of in silico approach for prediction of presence of opioid peptides in wheat
by: Swati Garg, et al.
Published: (2018-02-01)

Multiple Sclerosis: Immunopathology and Treatment Update
by: Narges Dargahi, et al.
Published: (2017-07-01)

Bioterrorism preparedness : medicine - public health - policy /
by: Khardori, Nancy
Published: (2006)

W254 in furin functions as a molecular gate promoting anti-viral drug binding: Elucidation of putative drug tunneling and docking by non-equilibrium molecular dynamics
by: Harry Ridgway, et al.
Published: (2023-01-01)

Inflammation: The Cause of All Diseases
by: Vivek P. Chavda, et al.
Published: (2024-11-01)

A Veterinary Vaccine for SARS-CoV-2: The First COVID-19 Vaccine for Animals
by: Vivek P Chavda, et al.
Published: (2021-06-01)

Identification and Effects of Skim Milk-Derived Bioactive Antihypertensive Peptides
by: Fatah B. Ahtesh, et al.
Published: (2021-12-01)

Editorial: Peptides against infectious diseases: from antimicrobial peptides to vaccines
by: Joanna Bojarska, et al.
Published: (2024-12-01)

Role of Angiotensin II in Cardiovascular Diseases: Introducing Bisartans as a Novel Therapy for Coronavirus 2019
by: Jordan Swiderski, et al.
Published: (2023-05-01)

Receptor Interactions of Angiotensin II and Angiotensin Receptor Blockers—Relevance to COVID-19
by: Graham J. Moore, et al.
Published: (2021-07-01)

Development and validation of a new method to isolate, expand, and differentiate circulating osteogenic precursor (COP) cells
by: Jack Feehan, et al.
Published: (2021-12-01)

Molecular Epidemiology of SARS-CoV-2: The Dominant Role of Arginine in Mutations and Infectivity
by: Harry Ridgway, et al.
Published: (2023-01-01)

Biodefense Implications of New-World Hantaviruses
by: Michael Hilary D’Souza, et al.
Published: (2020-08-01)

Vaccine Delivery Methods into the Future
by: Vasso Apostolopoulos
Published: (2016-03-01)

COVID-19 Vaccines in the Pipeline, Are Antibodies Adequate?
by: Md Kamal Hossain, et al.
Published: (2021-03-01)

Rational Design and Synthesis of Altered Peptide Ligands based on Human Myelin Oligodendrocyte Glycoprotein 35–55 Epitope: Inhibition of Chronic Experimental Autoimmune Encephalomyelitis in Mice
by: Theodore Tselios, et al.
Published: (2014-11-01)

Detection of vaccine-derived poliovirus type-3 in sewage of Kathmandu Valley, Nepal
by: Rachana Mehta, et al.
Published: (2024-11-01)

Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab
by: Despoina Florou, et al.
Published: (2020-10-01)

The 100 Days Mission—2022 Global Pandemic Preparedness Summit
by: Dimitrios Gouglas, et al.
Published: (2023-03-01)

The last oracle /
by: 453948 Rollins, James
Published: (2008)

Plague /
by: 419040 Birken, Gary A.
Published: (2002)

Rethinking Gain-of-Function Experiments in the Context of the COVID-19 Pandemic
by: Michael J. Imperiale, et al.
Published: (2020-08-01)

Enhancing bioterrorism defense, leveraging animal models for viral drug and vaccine development: a review article
by: Hadi Lotfi, et al.
Published: (2023-10-01)

The invisibles: the role of volunteer emergency service members in human health emergency response
by: Megan Crane
Published: (2019-02-01)

Circulating osteogenic precursor cells: Building bone from blood
by: Jack Feehan, et al.
Published: (2019-01-01)

Computational Evidence for Bisartan Arginine Blockers as Next-Generation Pan-Antiviral Therapeutics Targeting SARS-CoV-2, Influenza, and Respiratory Syncytial Viruses
by: Harry Ridgway, et al.
Published: (2024-11-01)

Understanding the Driving Forces That Trigger Mutations in SARS-CoV-2: Mutational Energetics and the Role of Arginine Blockers in COVID-19 Therapy
by: Harry Ridgway, et al.
Published: (2022-05-01)